CDKN2A and neoplasm: In this case only, the tumor is characterized by a low TMB, a wild-type p53 status, p16 overexpression and the concomitant wild-type status of the genes INK4 (which encodes for p16), EGFR and CCND1 (the gene encoding for cyclin D1).